Clinical Trials Directory

Trials / Completed

CompletedNCT02217306

Contrast Sensitivity and Diabetic Macular Edema

Status
Completed
Phase
Study type
Observational
Enrollment
132 (actual)
Sponsor
Hospital Juarez de Mexico · Other Government
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Contrast sensitivity is a tool use to evaluate the visual function in all patients. It can be modified by different pathologies or by age. The purpose of this study is to identify the changes that could be in relationship with the course of diabetic retinopathy comparing with diabetic patient without retinopathy and in patients with diabetic macular edema so if it is a difference, research for therapeutic strategies to improve it in this patients.

Detailed description

Contrast sensitivity is defined as a subjective measurement, it is the ability to separate the image between figure and background, taking into account the minimum amount of light required; it is evaluated by the contrast threshold, which is the smallest amount of contrast needed to be able to see a target and solve their characteristics, would be his reciprocal value. Medina et al. curve reported in healthy Mexicans SC 5 to 80, where \> 51 years have decreased compared to contrast sensitivity studies international; further that contrast sensitivity in older groups of 41 years is decreased high frequency.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2014-07-01
Completion
2014-08-01
First posted
2014-08-15
Last updated
2014-08-15

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02217306. Inclusion in this directory is not an endorsement.